The integration of Cellomics® Store with the EMC Centera CAS storage solution provides a best-in-class software and hardware platform for the management, storage, analysis, and archiving of cellular image data. End-users can create, manage, and analyze high content screening experiments, cellular image data, and discover relationships for potential targets, lead compounds, and genes. Images which are the ‘raw’ data of HCS are critical content assets that can now be secured with the EMC Centera providing a trusted, scalable, and cost-effective content store. Centera Compliance Edition protects intellectual property and discovery through content authenticity making it tamper-proof down to the individual image level. Commenting on the integration, Terry Dunlay, VP of Informatics Products at Cellomics stated “The extension of our Store product with EMC’s Centera system will provide our customers with complete flexibility for management of HCS and image data, while enabling regulatory compliance. Furthermore, working with EMC is an important part of our strategy for expanding HCS informatics. Many of our customers request a turnkey solution for their HSC data management, so we worked closely with EMC, and have delivered a solution that our customers can quickly deploy.” EMC’s Roy Sanford, VP of Content Addressed Storage, commenting on the integration said “ With the integration of the Cellomics Store with Centera Compliance Edition, life sciences companies can set hardened retention periods on electronic records further enabling compliance with regulations including the GxPs and 21 CFR Part 11. We look forward to bringing our solutions to life science customers to further accelerate the drug discovery process with Cellomics as the first dedicated high content screening solution (HCS) with Centera.” About Cellomics Cellomics, Inc. is pioneering the field of cellular knowledge extraction. Its unique technology integrates fluorescence-based reagents, cell lines, multi-parametric assays, HCS instrumentation (both fixed end-point and kinetic systems), and informatics tools to achieve a flexible, broadly applicable platform for users in the life sciences. This automated platform, when applied to early drug discovery is proving to reduce the 'idea-to-discovery' cycle time in drug discovery, while increasing the probability of the therapeutic success of leads as well as reducing the cycle time in basic research. Cellomics’ proprietary platform, including the ArrayScan® and KineticScan® HCS Readers, along with its vHCS™Discovery Toolbox software and automated analysis applications, are in use at multiple sites within all of the top fifteen pharmaceutical companies in the world, as well as leading pharmaceutical and biotechnology companies and academic centers globally. About EMC EMC Corporation (NYSE: EMC) is the world leader in information storage systems, software, networks and services, providing automated networked storage solutions that enable organizations of all sizes to better and more cost-effectively manage, protect and share their information. More information about EMC’s products and services can be found at www.EMC.com.

For further information, contact:

Judy P. Masucci, PhD
Director, Marketing
Cellomics, Inc.
100 Technology Drive
Pittsburgh, PA 15219
412.770.2353
412.770.2450 (fax)